Ascendis Pharma A ASND
NASDAQ ASND
$270.67 -0.45 (-0.16%)
As of: Sep 4, 2026 · 3:59 PM EDT

Ascendis Pharma A (ASND) Prepaid Assets (2012 - 2026)

Ascendis Pharma A (ASND) posted Prepaid Assets of $45.2 million for Q1 2026, up 15.06% sequentially from $39.2 million in Q4 2025, and up 27.49% YoY from $35.4 million in Q1 2025.

Analysis

Ascendis Pharma A (ASND) Prepaid Assets (2012 - 2026) Analysis & Trends

Ascendis Pharma A has reported Prepaid Assets for 15 years, with the latest figure at $45.2 million in Q1 2026.

  • Quarterly Prepaid Assets rose 27.49% year-over-year to $45.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.2 million (up 27.49% YoY) and the FY2025 annual result came in at $39.2 million, up 29.92% from the prior year.
  • Prepaid Assets grew to $45.2 million in Q1 2026 per ASND's latest filing, from $39.2 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $46.8 million in Q2 2023 and troughed at $30.2 million in Q4 2024.
  • A 5-year average of $38.4 million and a median of $38.8 million in 2025 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 70.0% in 2022, then fell 27.22% in 2024.
  • Over 5 years, Prepaid Assets stood at $32.4 million in 2022, then climbed by 28.27% to $41.5 million in 2023, then retreated by 27.22% to $30.2 million in 2024, then grew by 29.92% to $39.2 million in 2025, then grew by 15.06% to $45.2 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $45.2 million, $39.2 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ascendis Pharma A 16.39 Bn 15.45 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.53 Mn
Mar 31, 2026 45.16 Mn
Dec 31, 2025 39.25 Mn
Sep 30, 2025 34.39 Mn
Jun 30, 2025 38.84 Mn
Mar 31, 2025 35.42 Mn
Dec 31, 2024 30.21 Mn
Sep 30, 2024 35.63 Mn
Jun 30, 2024 39.57 Mn
Mar 31, 2024 46.17 Mn
Dec 31, 2023 41.51 Mn
Sep 30, 2023 41.72 Mn
Jun 30, 2023 46.78 Mn
Mar 31, 2023 41.53 Mn
Dec 31, 2022 32.36 Mn
Sep 30, 2022 34.85 Mn
Jun 30, 2022 37.42 Mn
Mar 31, 2022 31.42 Mn
Dec 31, 2021 28.86 Mn
Sep 30, 2021 26.23 Mn